Menu
Close
Active investors backing this sector, from the Cut Through Venture investor database.
This page lists investors from the Cut Through Venture investor database that back Australian biotech, medtech and life sciences companies, including specialist life science funds, university-linked investors and generalist VCs with a healthcare practice.
Biotech and medtech is Australia's deepest research-driven sector. It ranked third by capital in 2025 with $829M and led every sector on deal count with 49 deals, according to the State of Australian Startup Funding 2025. Victoria is the national hub, with biotech and medtech raising $526M there in 2025 per the Victoria Venture Capital Report 2025. Median rounds in life sciences tend to be smaller and earlier than the market average.
Filter by stage to find funds with the right mandate, and read the latest reports for sector benchmarks.
Wollemi Capital (TreeArc Investment Group) is an impact fund based in Sydney, investing from angel and pre-seed through seed and Series A. Founded in 2021 by Tim Bishop and Paul Hunyor, it raised a $220 million round backed by Commonwealth Bank of Australia and invests across climate and energy, vertical business software, healthtech and hardware and robotics. Recent investments include Vexev and ExoFlare.
View profileVirescent Ventures is a venture capital fund based in Sydney, investing from seed through Series A, Series B+ and strategic rounds. Launched by Australia's Clean Energy Finance Corporation, it manages more than $500 million and backs companies across hardware and robotics, climate and energy and life sciences and biotech. Recent investments include MicroTau and Amber Electric.
View profileUNSW Founders is an accelerator based in Sydney, backing companies at the angel, pre-seed, seed and accelerator stages. Founded in 2018 and based at the Michael Crouch Innovation Centre, it has supported more than 140 companies across hardware and robotics, life sciences and biotech, climate and energy and AI infrastructure. Recent investments include VOQO AI and GonGlobal.
View profileUniversity of New South Wales is a university-linked investor based in Sydney, backing companies from seed through accelerator, Series A and Series B+ stages via its Barker Street Ventures platform. Over the past decade, UNSW-linked ventures have attracted a cumulative $5.6 billion in capital, with deals spanning marketplaces, vertical and horizontal business software and hardware and robotics. Recent investments include High Earth Orbit Robotics and JumpStart Fertility.
View profileUniversity of Melbourne Genesis is a university-linked fund based in Melbourne, backing companies from angel and pre-seed through seed and accelerator stages. Launched in 2024 as a $15 million pre-seed fund with Breakthrough Victoria, it targets research spinouts across climate and energy, life sciences and biotech, horizontal business software and AI infrastructure. Recent investments include Fluent and exteRNA.
View profileUniversity of Melbourne is a university-linked investor based in Melbourne, backing companies from angel and pre-seed through seed, Series A and Series B+ rounds via its research commercialisation office. It co-launched the $15 million Genesis Pre-Seed Fund with Breakthrough Victoria and backs deals across life sciences and biotech, horizontal business software, hardware and robotics and healthtech. Recent investments include Kali Healthcare and PredicTx Health.
View profileUniseed is a university-linked investor based in Brisbane, investing from angel and pre-seed through seed, Series A and Series B+ rounds. Founded in 2000 and jointly owned by nine Australian universities plus CSIRO, it has backed more than 70 companies across life sciences and biotech, hardware and robotics, climate and energy and vertical business software. Recent investments include Ferronova and DeteQt.
View profileTrampoline Syndicate is an angel syndicate based in Sydney, backing companies at the angel and pre-seed stage. It has more than 250 wholesale investors voting deal by deal on each opportunity, with deals spanning life sciences and biotech and consumer tech, and has completed 16 deals to date. Recent investments include Spoony App and Magnetica.
View profileTin Alley Ventures is a university-linked venture fund based in Melbourne, investing from seed through to accelerator and Series B+ stages. Created by the University of Melbourne with Tanarra Capital, it manages $125 million backing deep tech spinouts across horizontal business software, climate and energy, life sciences and biotech and AI infrastructure. Recent investments include Apromore and Proxima Bio.
View profileTenmile is a venture capital fund based in Perth, investing from seed through Series A and Series B+ rounds. Launched by Andrew Forrest's Tattarang in 2022 with $250 million in committed capital, it backs health technology companies across life sciences and biotech and healthtech. Recent investments include AdvanCell and Mindset Health.
View profileTechstars is an accelerator based in Boulder, Colorado, running seed and pre-seed programs through to Series A across its global cohorts. Founded in 2006 by David Cohen, its portfolio spans AI infrastructure, hardware and robotics, horizontal business software and healthtech, and includes 29 unicorns such as Uber, Twilio and DigitalOcean. Recent investments include Manifest and VetNotes.
View profileSydney Angels is an angel network based in Sydney, backing angel, pre-seed and seed companies through to Series A. It invests across horizontal and vertical business software, fintech and hardware and robotics, and runs more than 100 members across regional chapters alongside its Sidecar Fund. Recent investments include Mary Technology and Keeyu.
View profileSparkLabs Cultiv8 is an accelerator based in Orange, New South Wales, founded in 2017, running pre-seed and seed stage programs. It focuses on agri-food technology spanning climate and energy, hardware, robotics and sensors, consumer brands and vertical business software, and has accelerated 53 global startups within the NSW Department of Primary Industries ecosystem. Recent investments include PyxGlobal and Carbon Friendly.
View profileProto Axiom is a Sydney-based venture capital fund, founded in 2021, investing from seed through to Series A and Series B and beyond. Its recent deals are concentrated in life sciences and biotech, and it operates a company-creation model, building the companies it invests in using permanent capital and running the related Women's Health Foundry. Recent investments include AdvanCell Isotopes and JumpStart Fertility.
View profileM8 Ventures is a Sydney-based venture capital fund backing pre-seed, seed and Series A companies. Its recent deals span healthtech, life sciences and biotech, and horizontal business software, and the fund was co-founded in 2024 by Emily Rich and Alan Jones. Recent investments include Elita and Hola Health.
View profileIP Group is a university-linked investor based in London, founded in 2001 and backing seed through Series B companies. It commercialises intellectual property from universities across hardware and robotics, life sciences, cybersecurity and climate and energy, and expanded into Australia in 2017 with $100 million committed alongside the Group of Eight universities. Recent investments include amsl aero and Hysata.
View profileInterValley Ventures is a venture capital fund based in Sydney, founded in 2019 and backing seed through Series B companies. It invests across life sciences, hardware and robotics, cybersecurity and consumer tech, and is affiliated with Mizuho Financial Group to help portfolio companies expand into Japan. Recent investments include QuintessenceLabs and Quantum Brilliance.
View profileGrok Ventures is the family office of Mike and Annie Cannon-Brookes, based in Sydney and investing from seed through to Series B and beyond. It focuses on fintech, climate and energy, consumer brands and life sciences, and pivoted to a climate technology investment mandate around 2021. Recent investments include Fleet and Spriggy.
View profileBrisbane Angels is a Brisbane-based angel network that backs pre-seed and seed companies. It describes itself as Australia's largest angel investing group, connecting members with high-growth Queensland and Australian startups, with recent deals spanning hardware and robotics, consumer tech, vertical business software and healthtech. Recent investments include Avarni and Obzervr.
View profileBreakthrough Victoria is a Melbourne-based government-owned investment fund, launched in 2021, that invests from pre-seed through to growth capital rounds. Owned by the Victorian Government, it provides patient capital across advanced manufacturing, clean economy, digital technologies and health and life sciences, with recent deals spanning hardware and robotics, climate and energy, education and life sciences and biotech. Recent investments include GonGlobal and Amber Electric.
View profileBrandon Capital is a Melbourne-based venture capital fund that invests from seed through to growth rounds. Founded by Chris Nave and Stephen Thompson, it focuses on life sciences and biotech, healthtech and consumer tech, and closed its Fund Six at more than $430 million in 2025 with a $150 million commitment from the National Reconstruction Fund Corporation. Recent investments include AdvanCell Isotopes and Lumonus.
View profileAustralian Medical Angels is a Melbourne-based angel network that backs pre-seed through to Series A companies. It brings together more than 1,000 clinician investors focused on healthcare and medtech, with recent deals spanning life sciences and biotech, healthtech and fintech, and it recently launched the $40 million Medical Angels Venture Fund I. Recent investments include HAMR Energy and Coviu.
View profileAngelLoop is a Brisbane-based angel network that backs pre-seed and seed companies. It operates as a Queensland not-for-profit connecting entrepreneurs with angel investors rather than investing directly, with engagement spanning vertical software, healthtech, life sciences and biotech, and marketplaces. Recent investments include ProSeek Bio and Gelomics.
View profileAlberts Impact Ventures is a Sydney-based impact fund that invests from seed through to later growth rounds. It backs companies across equality, culture, healthy minds and sustainable environment themes, with recent deals spanning marketplaces, vertical software, climate and energy, and life sciences and biotech, and combines venture investing with philanthropy through the Tony Foundation. Recent investments include Sendle and Bygen.
View profileTEN13 is a venture syndicate based in Brisbane, investing from angel and pre-seed through seed, Series A and Series B+ rounds. Founded by Steve Baxter and Stew Glynn, it has deployed more than $125 million since 2019 across deals spanning vertical business software, education, marketplaces and consumer brands. Recent investments include Bower and AutoGrab.
View profileTall Order Ventures, formerly Skalata Ventures, is a venture capital fund based in Melbourne, investing from pre-seed through Series B+. It describes itself as a first-cheque fund backing AI-native founders across vertical business software, horizontal business software, education and training and marketplace sectors, and is raising Fund III with cheques up to $1 million. Recent investments include Enrola and Viewa.
View profileWunala Capital is a growth and private equity firm based in Sydney, providing late-stage capital at Series B and beyond. It manages the Wunala Capital Emerging Opportunities Fund, offering bridge and pre-IPO financing across horizontal business software, fintech, life sciences and biotech and space and defence. Recent investments include Send Payments and Marketplacer.
View profileTouch Ventures is an ASX-listed investment company based in Sydney, backing companies from seed through Series A and Series B+ rounds. It provides growth capital of $3 million to $10 million across marketplaces, vertical business software, cybersecurity and fintech, investing both locally and offshore. Recent investments include Sendle and Ordermentum.
View profileTenacious Ventures is a venture capital fund based in Melbourne, backing companies from angel and pre-seed through seed and Series A. It focuses on agrifood and climate technology, with deals spanning climate and energy, life sciences and biotech, hardware and robotics and horizontal business software. Recent investments include Nbryo and SwarmFarm Robotics.
View profileSquare Peg is a venture capital fund based in Melbourne, founded in 2012, investing from pre-seed through Series B+. The firm manages billions of US dollars in assets under management, backing deals across fintech, life sciences and biotech, healthtech and vertical business software in Australia, New Zealand, Southeast Asia and Israel. Recent investments include Alloy and Constantinople.
View profileStoic Venture Capital is a university-linked investor based in Sydney, founded in 2019, investing from pre-seed through Series B+. It describes itself as Australia's first university-focused venture fund, backing life sciences and biotech, hardware, robotics and sensors and climate and energy with cheques of roughly $100,000 to $1 million. Recent investments include Kinoxis Therapeutics and Ena Respiratory.
View profileStartmate is an accelerator based in Sydney, founded in 2010 by Niki Scevak, investing from pre-seed through Series B+. It runs cohort-based programs across marketplace, vertical business software, horizontal business software and climate and energy, with a portfolio of over 350 companies valued at a combined $4.5 billion. Recent investments include EstiMate AI and GlowBack.
View profileSkip Capital is a family office based in Sydney, investing from pre-seed through Series B+. It is the private investment fund of Atlassian co-founder Scott Farquhar and Kim Jackson, with deals spanning hardware, robotics and sensors, consumer brands, vertical business software and fintech. Recent investments include Alloy and MicroTau.
View profileSide Stage Ventures is a venture capital fund based in Sydney, founded in 2023, investing from pre-seed through Series A. It runs a $15 million fund across consumer brands, healthtech, AI models and data infrastructure and horizontal business software, co-founded by Markus Kahlbetzer and Ben Grabiner. Recent investments include Kantoko and Fabra.
View profileShearwater Capital is a growth and private equity investor based in Sydney, founded in 2018, backing companies from pre-seed through Series B+. It invests roughly $100 million of its 3 founder-partners' own capital across hardware, robotics and sensors, vertical business software, life sciences and biotech and horizontal business software. Recent investments include Parallel and Factory.
View profileScale Investors is an angel network based in Melbourne, backing companies from pre-seed through Series A. It describes itself as Australia's first angel network focused on women-led startups, with deals spanning education and training, life sciences and biotech, marketplace and hardware, robotics and sensors. Recent investments include Baymatob and ProSeek Bio.
View profileRampersand is a venture capital fund based in Melbourne, founded in 2013, investing from pre-seed through Series B+. Its recent deals span fintech, marketplace, horizontal business software and life sciences and biotech, and it has deployed over $100 million across 4 funds since inception. Recent investments include Parachute and Cuttable.
View profilePurpose Ventures is a Perth-based venture capital fund backing pre-seed, seed and angel-stage companies. Its recent deals span education, healthtech, life sciences and biotech and hardware and robotics, and the fund, worth $55 million and industry-agnostic, is led by General Partners Derek and Kylie Gerrard. Recent investments include Evatto and Coursebox.
View profilePossible Ventures is a Sydney-based venture capital fund backing pre-seed, seed and Series A companies. Its recent deals span climate and energy, life sciences and biotech, space and defence and healthtech, and it rebranded from Inventures Collective around June 2024. Recent investments include Heidi Health and Arlula.
View profileOneVentures is a Sydney-based venture capital fund investing at Series A and Series B and beyond. Its recent deals span healthtech, life sciences and biotech, marketplaces and vertical business software, and it manages $1 billion or more in assets across growth equity, growth credit and healthcare investment pillars. Recent investments include Vaxxas and Employment Hero.
View profileMandalay Venture Partners is a Melbourne-based venture capital fund backing seed-stage companies. Its recent deals span hardware and robotics, vertical business software, life sciences and biotech, and consumer brands, and its focus is sustainable agriculture and food-tech, with a first fund targeting $50 million backed by cornerstone investors NRMA and St Baker. Recent investments include Nbryo and Restoke.
View profileMain Sequence is a Sydney-based venture capital fund, founded in 2017, investing from pre-seed and seed through to Series A and Series B and beyond. Its recent deals span climate and energy, hardware and robotics, space and defence and AI infrastructure, and it spun out of CSIRO, Australia's national science agency, raising a $450 million third fund in 2022. Recent investments include Kinoxis Therapeutics and Avarni.
View profileJelix Ventures is a venture capital fund based in Sydney, backing pre-seed through Series A companies across Australia and New Zealand. It invests in hardware and robotics, climate and energy, and vertical and horizontal business software, operating as a corporate authorised representative serving wholesale and sophisticated investors only. Recent investments include PropHero and Quantum Brilliance.
View profileInvestible is a venture capital fund based in Sydney, founded in 2018 and investing from pre-seed through Series A with capacity to follow on. It backs marketplace, vertical and horizontal business software and fintech companies from offices in Sydney and Singapore, and runs Club Investible, a syndicate of more than 250 co-investors. Recent investments include Apate AI and PlasmaLeap Technologies.
View profileGiant Leap is an impact fund based in Melbourne, founded in 2016 and investing from pre-seed through to Series B. It backs hardware and robotics, marketplace, education and consumer brand companies across climate, health and social-impact themes, and holds an AFSL for its 30 plus portfolio companies. Recent investments include Teacher's Buddy and indi.
View profileGandel Invest is a family office based in Melbourne, investing from seed through growth equity and Series B rounds. It backs marketplace, vertical business software, consumer brand and fintech companies as part of the Gandel family's broader investment activities. Recent investments include pay.com.au and EatClub.
View profileGalileo Ventures is a venture capital fund based in Sydney, founded in 2020 and backing pre-seed and seed companies. It invests across vertical business software, healthtech, AI infrastructure and hardware and robotics, with offices in Sydney, Melbourne and San Francisco and typical cheques of $200,000 to $500,000. Recent investments include Relevance AI and Isaacus.
View profileFlying Fox Ventures is a venture capital fund based in Melbourne, founded in 2017 and backing pre-seed through Series B companies. It invests across horizontal and vertical business software, life sciences and biotech, and fintech, drawing on a large angel investor community and a $20 million fund with more than 100 portfolio companies. Recent investments include Operata and Safewill.
View profileCP Ventures is a venture capital fund based in Sydney, backing pre-seed through Series A companies globally. It invests across vertical business software, hardware and robotics, fintech and consumer tech, typically writing cheques of $100,000 to $500,000. Recent investments include LeadStory and MGA Thermal.
View profileAirTree Ventures is a Sydney-based venture capital fund that invests from pre-seed through to growth-stage rounds. Its recent deals span fintech, healthtech, education and vertical software, and it announced a $250 million seed fund alongside a $400 million growth fund in 2025. Recent investments include High Earth Orbit Robotics and Gridsight.
View profileAcorn Capital is a Melbourne-based fund manager that invests from Series A through to growth rounds. It runs multiple vehicles, including a listed investment fund and microcap funds, and its recent deals span fintech, life sciences and biotech, and vertical and horizontal business software. Recent investments include Liquid Instruments and Conflux Technology.
View profileArtesian is a Sydney-based venture capital fund, founded in 2004, that invests from pre-seed through to growth rounds. It manages roughly $1.5 billion across debt and venture platforms, with recent deals spanning life sciences and biotech, cybersecurity, space and defence, and healthtech, and has backed more than 600 ventures under founders Jeremy Colless and Matt Clunies-Ross. Recent investments include Elita and Strong Room AI.
View profileArchangel Ventures is a Sydney-based venture capital fund that invests from pre-seed through to later growth rounds. It backs companies across Australia and South East Asia, with recent deals spanning healthtech, vertical software, education and fintech, and is currently deploying its 2026 Fund. Recent investments include Sophiie and Refresh.
View profileBlackbird is a Sydney-based venture capital fund that invests from pre-seed through to growth-stage rounds. It backs companies across Australia and New Zealand, with a portfolio valued at more than $10 billion across 100+ companies, and recent deals spanning hardware and robotics, consumer brands, healthtech and vertical software. Recent investments include OpenDebt and Heidi Health.
View profileAlium Capital is a Sydney-based growth and private equity investor that invests from pre-seed through to later-stage rounds. Founded in 2016, it invests in private, secondary and public technology companies across Australia and New Zealand, with recent deals spanning consumer tech, education, fintech and vertical software, and has recorded nearly 40 exits since inception. Recent investments include Quantum Brilliance and Atmo Biosciences.
View profile
